Histone deacetylase inhibitor FR901228 enhances adenovirus infection of hematopoietic cells

Blood

Volumn 99, Issue 6, 2002, Pages 2248-2251

  Kitazono, Masaki ^a,b   Rao, Vemulkonda Koneti ^a,b   Robey, Rob ^a,b   Aikou, Takashi ^a,b   Bates, Susan ^a,b   Fojo, Tito ^a,b   Goldsmith, Merrill E ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CD34 ANTIGEN; DEPSIPEPTIDE; FR 901228; GRANULOCYTE COLONY STIMULATING FACTOR; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; INTEGRIN; RECEPTOR; RNA;

ACETYLATION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENE THERAPY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; INCUBATION TIME; MONONUCLEAR CELL; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TRANSGENE; VIRUS INFECTION; VIRUS LOAD;

EID: 0037085773     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.6.2248     Document Type: Article

References (29)

1. Selective elimination (purging) of contaminating malignant cells from hematopoietic stem cell autografts using recombinant adenovirus
2. Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources
3. Maturation and lineage-specific expression of the Coxsackie and adenovirus receptor in hematopoietic cells
4. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5
5. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
6. 5 promote adenovirus internalization but not virus attachment
7. Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells
8. Adenovirus as a gene therapy vector for hematopoietic cells
9. Enhancement of adenovirus-mediated gene transfer to human bone marrow cells
10. Highefficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors
11. Efficient adenoviral vector transduction of human hematopoietic SCID-repopulating and longterm culture-initiating cells
12. Adenoviral vector-mediated gene transfer to primitive human hematopoietic progenitor cells: Assessment of transduction and toxicity in long-term culture
13. Gene transfer into human bone marrow hematopoietic cells mediated by adenovirus vectors
14. Transduction of primitive human hematopoietic cells with recombinant adenovirus vectors
15. Lipofectamine and related cationic lipids strongly improves adenoviral infection efficiency of primitive human hematopoietic cells
16. Genetic manipulation of primitive leukemic and normal hematopoietic cells using a novel method of adenovirus-mediated gene transfer
17. A potential molecular approach to ex vivo hematopoietic expansion with recombinant epidermal growth factor receptor-expressing adenovirus vector
18. Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector
19. Selective transduction of murine myelomonocytic leukemia cells (WEHI-3B) with regular and RGD-adenoviral vectors
20. 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery
21. FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968, I: Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity
22. FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor
23. Amplification of recombinant adenoviral transgene products occurs by inhibition of histone deacetylase
24. Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo
25. Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228
26. Sodium butyrate inhibits histone deacetylation in cultured cells
27. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A
28. Differential effects of adenovirus-p16 on bladder cancer cell lines can be overcome by the addition of butyrate
29. Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms